Pharmacokinetics: Driving Drug Development and Personalized Medicine
*Corresponding Author:Received Date: Jun 02, 2026 / Published Date: Jun 30, 2026
Citation: Brooks E (2026) Pharmacokinetics: Driving Drug Development and Personalized Medicine. cpb 15: 581.
Copyright: 2026 Ethan Brooks This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This compilation of research underscores the central role of pharmacokinetics (PK) in drug development and clinical practice. It covers ADME processes, drug-drug interactions, PBPK modeling, bioavailability enhancement, genetic influences, monoclonal antibody PK, disease state effects, transporter roles, food effects, and therapeutic drug monitoring. The collective insights emphasize PK’s critical contribution to optimizing drug efficacy and patient safety
